Cross-sectional and prospective study of the association between lung function and prediabetes

BMJ Open

Volumn 3, Issue 2, 2013, Pages

  Yamane, Takashi ^a,b   Yokoyama, Akihito ^a   Kitahara, Yoshihiro ^b   Miyamoto, Shintaro ^a   Haruta, Yoshinori ^b   Hattori, Noboru ^b   Yamane, Kiminori ^b,c   Hara, Hitoshi ^c   Kohno, Nobuoki ^b  

^a KOCHI UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c 11 40 Hijiyamahonmachi   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; JAPANESE; LONGITUDINAL STUDY; LUNG FUNCTION; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

EID: 84875031226     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-002179     Document Type: Article

References (33)

1. Engström G, Janzon L. Risk of developing diabetes is inversely related to lung function: a population-based cohort study. Diabet Med 2002;19:167-70. (Pubitemid 34225233)
2. Ford ES, Mannino DM; National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care 2004;27:2966-70. (Pubitemid 39565067)
3. Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and type 2 diabetes: findings from the British Women's Heart and Health Study. Diabetologia 2004;47:195-203. (Pubitemid 38315355)
4. Yeh HC, Punjabi NM, Wang NY, et al. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetes Care 2008;31:741-6.
5. Lee HM, Le H, Lee BT, et al. Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality. Eur Respir J 2010;36:1002-6.
6. Hickson DA, Burchfiel CM, Liu J, et al. Diabetes, impaired glucose tolerance, and metabolic biomarkers in individuals with normal glucose tolerance are inversely associated with lung function: the Jackson Heart Study. Lung 2011;189:311-21.
7. Klein OL, Krishnan JA, Glick S, et al. Systematic review of the association between lung function and type 2 diabetes mellitus. Diabet Med 2010;27:977-87.
8. Heianza Y, Arase Y, Tsuji H, et al. Low lung function and risk of type 2 diabetes in Japanese men: the Toranomon Hospital Health Management Center Study 9 (TOPICS 9). Mayo Clin Proc 2012;87:853-61.
9. Kwon CH, Rhee EJ, Song JU, et al. Reduced lung function is independently associated with increased risk of type 2 diabetes in Korean men. Cardiovasc Diabetol 2012;11:38.
10. Sinden NJ, Stockley RA. Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence. Thorax 2010;65:930-6.
11. Mannino DM, Thorn D, Swensen A, et al. Prevalence and outcome of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008;32:962-9.
12. Iwamoto H, Yokoyama A, Kitahara Y, et al. Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med 2009;179:35-40.
13. Feary JR, Rodrigues LC, Smith CJ, et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010;65:956-62.
14. Davis WA, Knuiman M, Kendall P, et al. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2004;27:752-7. (Pubitemid 38280545)
15. Ehrlich SF, Quesenberry CP Jr, Van Den Eeden SK, et al. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 2010;33:55-60.
16. Seshasai SR, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011;364:829-41.
17. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva: World Health Organization, 2006.
18. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-402.
19. Unwin N, Shaw J, Zimmet P, et al. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetes Med 2002;19:708-23. (Pubitemid 35013848)
20. Qiao Q, Jousilahti P, Eriksson J, et al. Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 2003;26:2910-14. (Pubitemid 37205567)
21. Gabir MM, Hanson RL, Dabelea D, et al. Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care 2000; 23:1113-18. (Pubitemid 30616798)
22. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001;24:1448-53. (Pubitemid 33716436)
23. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-36.
24. Committee report of pulmonary physiology in Japan Respiratory Society. Reference values for spirogram and arterial blood gas analysis in Japanese. (In Japanese.) Nihon Kokyuki Gakkai Zasshi 2001;39:1S-17S.
25. Abdul-Ghani MA, Jenkinson CP, Richardson DK, et al. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 2006;55:1430-5. (Pubitemid 44195383)
26. Eriksson KF, Lindgärde F. Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predicts of NIDDM in middle-aged Swedish men. Diabetologia 1996;39:573-9. (Pubitemid 26135460)
27. Burney PG, Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax 2011;66:49-54.
28. Guerra S, Sherrill DL, Venker C, et al. Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study. Thorax 2011;65:499-504.
29. Orfei L, Strachan DP, Rudnicka AR, et al. Early influences on adult lung function in two national British cohorts. Arch Dis Child 2008;93:570-4. (Pubitemid 352030077)
30. Sebert S, Sharkey D, Budge H, et al. The early programming of metabolic health: is epigenetic setting the missing link? Am J Clin Nutr 2011;94:1953S-8S.
31. Whincup PH, Kaye SJ, Owen CG, et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA 2008;300:2886-97.
32. Osmond C, Barker DJ. Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ Health Perspect 2000;108:545S-53S.
33. Barker DJ. The developmental origins of adult disease. J Am Coll Nutr 2004;23:588S-95S. (Pubitemid 40096746)